Marine Natural Products as Anticancer Agents 2.0
Funding
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- Wang, N.; Ma, T.; Yu, B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct. Target. Ther. 2023, 8, 69. [Google Scholar] [CrossRef] [PubMed]
- Mayer, A.M.S. The Global Marine Pharmaceuticals Pipeline. Available online: https://www.marinepharmacology.org/about (accessed on 5 April 2023).
- Li, Y.; McGowan, E.; Chen, S.; Santos, J.; Yin, H.; Lin, Y. Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. Mar. Drugs 2023, 21, 128. [Google Scholar] [CrossRef] [PubMed]
- Vasarri, M.; Barletta, E.; Degl’Innocenti, D. Marine Migrastatics: A Comprehensive 2022 Update. Mar. Drugs 2022, 20, 273. [Google Scholar] [CrossRef] [PubMed]
- Sala, S.; Moggach, S.A.; Nealon, G.L.; Fromont, J.; Gomez, O.; Vuong, D.; Lacey, E.; Flematti, G.R. Type-I Hemins and Free Porphyrins from a Western Australian Sponge Isabella sp. Mar. Drugs 2023, 21, 41. [Google Scholar] [CrossRef] [PubMed]
- Mohamed, T.A.; Elshamy, A.I.; Abdel-Tawab, A.M.; AbdelMohsen, M.M.; Ohta, S.; Pare, P.W.; Hegazy, M.-E.F. Oxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E. Mar. Drugs 2021, 19, 519. [Google Scholar] [CrossRef] [PubMed]
- Patel, P.A.; Bruun, T.; Ilina, P.; Mäkkylä, H.; Lempinen, A.; Yli-Kauhaluoma, J.; Tammela, P.; Kiuru, P.S. Synthesis and Cytotoxicity Evaluation of Spirocyclic Bromotyrosine Clavatadine C Analogs. Mar. Drugs 2021, 19, 400. [Google Scholar] [CrossRef] [PubMed]
- Lu, X.-X.; Jiang, Y.-Y.; Wu, Y.-W.; Chen, G.-Y.; Shao, C.-L.; Gu, Y.-C.; Liu, M.; Wei, M.-Y. Semi-Synthesis, Cytotoxic Evaluation, and Structure - Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity. Mar. Drugs 2022, 20, 26. [Google Scholar] [CrossRef] [PubMed]
- Suksamai, D.; Racha, S.; Sriratanasak, N.; Chaotham, C.; Aphicho, K.; Lin, A.C.K.; Chansriniyom, C.; Suwanborirux, K.; Chamni, S.; Chanvorachote, P. 5-O-(N-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling. Mar. Drugs 2022, 20, 235. [Google Scholar] [CrossRef] [PubMed]
- Alves, C.; Silva, J.; Pintéus, S.; Guedes, R.A.; Guedes, R.C.; Alvariño, R.; Freitas, R.; Goettert, M.I.; Gaspar, H.; Alfonso, A.; et al. Bromoditerpenes from the Red Seaweed Sphaerococcus coronopifolius as Potential Cytotoxic Agents and Proteasome Inhibitors and Related Mechanisms of Action. Mar. Drugs 2022, 20, 652. [Google Scholar] [CrossRef] [PubMed]
- Wu, Y.; Li, Y.; Guo, W.; Liu, J.; Lao, W.; Hu, P.; Lin, Y.; Chen, H. Laminaria japonica Peptides Suppress Liver Cancer by Inducing Apoptosis: Possible Signaling Pathways and Mechanism. Mar. Drugs 2022, 20, 704. [Google Scholar] [CrossRef] [PubMed]
- Su, Y.; Choi, H.S.; Choi, J.H.; Kim, H.-S.; Jang, Y.-S.; Seo, J.-W. 7S,15R-Dihydroxy-16S,17S-epoxy-docosapentaenoic Acid Overcomes Chemoresistance of 5-Fluorouracil by Suppressing the Infiltration of Tumor-Associated Macrophages and Inhibiting the Activation of Cancer Stem Cells in a Colorectal Cancer Xenograft Model. Mar. Drugs 2023, 21, 80. [Google Scholar] [CrossRef] [PubMed]
- Dong, S.; Chen, Z.; Wang, L.; Liu, Y.; Stagos, D.; Lin, X.; Liu, M. Marine Bromophenol Bis(2,3,6-Tribromo-4,5-Dihydroxybenzyl) ether Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells and Reduces Vasculogenic Mimicry in Human Lung Cancer A549 Cells. Mar. Drugs 2021, 19, 641. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alves, C.; Diederich, M. Marine Natural Products as Anticancer Agents 2.0. Mar. Drugs 2023, 21, 247. https://doi.org/10.3390/md21040247
Alves C, Diederich M. Marine Natural Products as Anticancer Agents 2.0. Marine Drugs. 2023; 21(4):247. https://doi.org/10.3390/md21040247
Chicago/Turabian StyleAlves, Celso, and Marc Diederich. 2023. "Marine Natural Products as Anticancer Agents 2.0" Marine Drugs 21, no. 4: 247. https://doi.org/10.3390/md21040247